In our study, we found that downregulation of BCL11A depressed EMT program in NB cells, including upregulation of the epithelial marker E-cadherin, as well as downregulation of mesenchymal markers (N-cadherin, slug, and vimentin). Here, BCL11A is linked to neuroblastoma.